Technical Description
TThe present invention relates to a bioactive glass nanocomposite for management of cancer through hyperthermia and controlled drug delivery.
Problems Addressed
- Limited Bioactivity
- Biocompatibility Challenges
- Reduced Drug Delivery Efficiency
- Hyperthermia Limitations
- Uncontrolled Cancer Management
Tech Features
- Efficient Cancer Management
- Controlled Drug Delivery
- Bone Tissue Regeneration
- Targeted Cancer Therapy
- Biocompatible & Antimicrobial
- Sustainable & Efficient Fabrication
Target Audience
- Medical & Healthcare Sector
- Pharmaceutical Industry
- Regenerative Medicine Industry
- Medical Device Manufacturing Sector
- Research & Development
Tech ID: P27-1403 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
